Drug Profile


Latest Information Update: 07 Nov 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator N. S. Kurnakov Institute of General and Inorganic Chemistry
  • Developer N. S. Kurnakov Institute of General and Inorganic Chemistry; Nonindustrial source
  • Class Antineoplastics; Platinum complexes; Small molecules
  • Mechanism of Action Protein kinase C inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer; Solid tumours

Most Recent Events

  • 28 Nov 2000 No-Development-Reported for Solid tumours in Russia (Unknown route)
  • 09 May 1995 Phase-II clinical trials for Solid tumours in Russia (Unknown route)
  • 04 May 1995 Preclinical development for Cancer in Germany (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top